Congress Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-115,428
Closed -$10.7M 364
2024
Q2
$10.7M Sell
115,428
-982
-0.8% -$87K 0.08% 179
2024
Q1
$11.1M Buy
116,410
+100
+0.1% +$8.4K 0.08% 175
2023
Q4
$8.87M Sell
116,310
-6,391
-5% -$445K 0.07% 183
2023
Q3
$8.5M Buy
122,701
+4,635
+4% +$372K 0.08% 172
2023
Q2
$11.1M Buy
118,066
+1,184
+1% +$103K 0.1% 161
2023
Q1
$9.67M Buy
116,882
+2,754
+2% +$216K 0.09% 166
2022
Q4
$8.52M Sell
114,128
-1,057
-0.9% -$81.5K 0.09% 166
2022
Q3
$9.52M Buy
115,185
+24,921
+28% +$2.4M 0.1% 158
2022
Q2
$8.58M Sell
90,264
-25,352
-22% -$2.62M 0.08% 170
2022
Q1
$13.6M Sell
115,616
-5,739
-5% -$644K 0.12% 132
2021
Q4
$15.7M Sell
121,355
-31,422
-21% -$3.67M 0.12% 108
2021
Q3
$17.3M Buy
152,777
+30,775
+25% +$3.51M 0.14% 94
2021
Q2
$12.6M Buy
122,002
+971
+0.8% +$91.5K 0.11% 111
2021
Q1
$10.1M Buy
121,031
+6,085
+5% +$514K 0.09% 126
2020
Q4
$10.5M Buy
114,946
+3,192
+3% +$265K 0.1% 114
2020
Q3
$8.92M Buy
111,754
+1,043
+0.9% +$81.4K 0.1% 115
2020
Q2
$7.65M Buy
110,711
+698
+0.6% +$49.6K 0.09% 123
2020
Q1
$6.92M Buy
110,013
+273
+0.2% +$19.7K 0.11% 115
2019
Q4
$8.53M Sell
109,740
-1,845
-2% -$144K 0.1% 116
2019
Q3
$8.18M Sell
111,585
-14,010
-11% -$984K 0.11% 102
2019
Q2
$7.73M Sell
125,595
-7,599
-6% -$459K 0.1% 119
2019
Q1
$8.49M Buy
133,194
+432
+0.3% +$24.7K 0.11% 103
2018
Q4
$6.78M Buy
132,762
+1,905
+1% +$96.4K 0.1% 122
2018
Q3
$7.59M Buy
130,857
+1,842
+1% +$90.1K 0.1% 132
2018
Q2
$6.26M Sell
129,015
-15,159
-11% -$708K 0.09% 148
2018
Q1
$6.71M Buy
144,174
+17,961
+14% +$780K 0.09% 133
2017
Q4
$4.74M Buy
126,213
+579
+0.5% +$21.2K 0.07% 172
2017
Q3
$4.58M Buy
125,634
+5,523
+5% +$211K 0.07% 177
2017
Q2
$4.73M Sell
120,111
-1,473
-1% -$53.8K 0.08% 146
2017
Q1
$3.81M Sell
121,584
-7,650
-6% -$240K 0.07% 164
2016
Q4
$4.04M Buy
129,234
+19,356
+18% +$627K 0.08% 159
2016
Q3
$4.42M Buy
+109,878
New +$4.14M 0.1% 141

Other funds holding EW